Senliang Pan

Title: The Innovative Contributions of Senliang Pan

Introduction

Senliang Pan is a notable inventor based in Flushing, NY (US). He has made significant contributions to the field of medical research, particularly in the fight against HIV. With a total of 2 patents, his work focuses on developing compounds that inhibit the HIV preintegration complex, thereby preventing viral infection.

Latest Patents

Senliang Pan's latest patents include groundbreaking innovations. The first patent, titled "HIV matrix protein tyrosine position 29 pocket binders," discloses a structural genus of compounds that bind amino moieties on neighboring lysine residues in a tyrosine residue 29 pocket of the matrix protein component of the HIV preintegration complex (PIC). This binding action prevents the PIC from associating with karyopherin .alpha., effectively blocking nuclear importation and integration of the HIV viral genome into the host cell DNA. The second patent, "HIV nuclear localization inhibitors," reveals a genus of compounds that exhibit anti-HIV infection therapeutic activity and inhibit the nuclear localization of the HIV preintegration complex.

Career Highlights

Senliang Pan is affiliated with the Picower Institute for Medical Research, where he conducts his research and development efforts. His work is pivotal in advancing therapeutic strategies against HIV, showcasing his commitment to improving public health.

Collaborations

Throughout his career, Senliang Pan has collaborated with esteemed colleagues, including Michael I Bukrinsky and Omar K Haffar. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.

Conclusion

Senliang Pan's contributions to HIV research through his patents and collaborations highlight his role as a significant inventor in the medical research community. His innovative work continues to pave the way for advancements in therapeutic strategies against viral infections.